Rapalogix Health, Inc.

Biotechnology · CARLSBAD, CA

BiotechnologySEC Form D

Rapalogix Health, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 26, 2026, reporting $19,112,746 raised toward a $24,999,999 offering.

Incorporated in Delaware and based in CARLSBAD, CA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Rapalogix Health, Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Rahul MehtaExecutive Officer
  • James PeyerDirector
  • Juliette HanDirector
  • Neetu DhaliwalDirector
  • Brent SaundersDirector
  • Doris DayDirector
  • David NicholsonDirector
  • Craig GordonDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$150.0KRaised

Chickadee Biomedicines, Inc.

BiotechnologyBOSTON, MA
Jun 22, 2026View SEC Form D
$500.0KRaised

Boston Interactome, Inc.

BiotechnologyALLSTON, MA
Jun 18, 2026View SEC Form D
$3.8MRaised

DINYA DNA, Inc.

BiotechnologyOAKLAND, CA
Jun 18, 2026View SEC Form D
$6.5MRaised

REGENTIS BIOMATERIALS LTD.

BiotechnologyHERZLIYA, L3
Jun 17, 2026View SEC Form D
$16.5MRaised

IceCure Medical Ltd.

BiotechnologyCAESAREA, L3
Jun 17, 2026View SEC Form D